American Urological Association Annual Meeting Research Articles

Hypertension Linked to Worse Upper Tract Urothelial Cancer Outcomes

Hypertension Linked to Worse Upper Tract Urothelial Cancer Outcomes

JU Open Plus: American Urological Association Annual Meeting 2023: Time With Our Science and the Mentors that Make It Happen

JU Open Plus: American Urological Association Annual Meeting 2023: Time With Our Science and the Mentors that Make It Happen

HF01-10 FRANK B. BICKNELL: PIONEER IN PEDIATRIC UROLOGY AND FOUNDER OF THE AMERICAN UROLOGICAL ASSOCIATION HISTORY FORUM

You have accessJournal of UrologyCME1 May 2022HF01-10 FRANK B. BICKNELL: PIONEER IN PEDIATRIC UROLOGY AND FOUNDER OF THE AMERICAN UROLOGICAL ASSOCIATION HISTORY FORUM Sutchin R. Patel, David A. Bloom, and Anthony A. Caldamone Sutchin R. PatelSutchin R. Patel More articles by this author , David A. BloomDavid A. Bloom More articles by this author , and Anthony A. CaldamoneAnthony A. Caldamone More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002541.10AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Dr. Frank B. Bicknell, a Michigan urologist, made significant contributions to the early field of pediatric urology and helped establish the history club and forum at the American Urological Association (AUA). METHODS: We researched the life of Dr. Bicknell via his publications, archived documents from the Didusch Museum and through the description of his life and accomplishments by his colleagues including John K. Lattimer and Frank Hinman Jr. RESULTS: Frank B. Bicknell (1907-1999) attended the University of Michigan (1925-1928) and the University of Michigan Medical School (1928-1932) prior to his internship and urology residency at the Receiving Hospital in Detroit, Michigan (1932-1936). He served in the Merchant Marine in the 1930s, was a major in World War II and served as Professor of Urology at Wayne State University. In 1951 Dr. Bicknell got together a small group of seven urologists interested in pediatric urology during the AUA Annual Meeting. Drs. Campbell, Barber, Johnson, Mertz, Hinman Jr. and Spence all met in Dr. Bicknell's Chicago hotel room and would form The Societies for Pediatric Urology. At the time, Dr. Bicknell's brother-in-law had just become president of the American Academy of Pediatrics (AAP). Dr. John Lattimer with the help of Dr. Bicknell's brother-in-law was able to get a room at the AAP meeting which he filled with 2500 people, thought to be the largest collection of urologists in one room at the time. The success of the session led to the organization of the AAP Section of Urology in 1960 (became a permanent section in 1971). It also impressed upon the AUA the magnitude of interest in pediatric urology. This allowed pediatric urologists to secure an exclusive session on the day before the main AUA meeting which has persisted since that time. In 1980, he wrote a text chapter "Pediatric Urology" describing the birth and history of the field and its current areas of study. Dr. Bicknell introduced a History of Urology Club at the 1965 AUA annual meeting. He chaired this popular event during its first decade, after which it was renamed the Forum on the History of Urology. The forum now occupies an entire afternoon during the annual meeting, with papers presented on historic urologic topics. The highlight of this assembly is the annual lecture on the history of medicine. In 2000, this oration was renamed the Frank Bicknell History of Urology Oration to honor the founder of the History Forum. CONCLUSIONS: Dr. Frank Bicknell was an early leader in pediatric urology and urologic history who helped found The Societies of Pediatric Urology and the AUA History Forum. Source of Funding: None © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e214 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Sutchin R. Patel More articles by this author David A. Bloom More articles by this author Anthony A. Caldamone More articles by this author Expand All Advertisement PDF DownloadLoading ...

Trends in Publication of Oncologic Abstracts Presented at the American Urological Association Annual Meeting: 1997-2017.

Our primary aim was to characterize eventual publication of presented American Urological Association (AUA) Annual Meeting oncology abstracts from 1997 to 2017. We hypothesized that the percentage of abstracts presented at the AUA Annual Meeting that became published peer-reviewed manuscripts increased over time. AUA Annual Meeting abstracts in "oncology" categories from 1997 to 2017 were identified. A random sample of 100 abstracts per year were assessed for publication. An abstract was considered "published" if 1) first and last author of the abstract were included on publication, 2) abstract and publication shared 1 conclusion, and 3) publication occurred from 1 year prior to the AUA Annual Meeting up to 10 years after. The search was conducted on PubMed® utilizing the MEDLINE® database. Over the 20-year observation period, 2,100 abstracts were reviewed and 56.3% were published. The number of journals in which manuscripts were published increased from 1997 to 2017 (R2=0.58, p <0.001), although here wasn't an increased publication rate for AUA Annual Meeting abstracts. Median time to publication was 1.1 years (IQR: 0.6-2.2). Median impact factor (IF) of publications was 3.3 (IQR 2.4-4.7). There was a decrease in median IF with longer interval to publication, from 3.6 within 1 year to 2.8 at more than 3 years (p=0.0003). Publications from multi-institutional abstracts had a higher mean IF (3.7 vs 3.1, p <0.0001). The majority of oncology abstracts presented at the AUA Annual Meeting are published. Despite growth in the number of journals and rise in IF among top urology journals, the rate of publication and IF were stable over time.

Quantifying Publication Rates and Time to Publication for American Urological Association Podium Presentations.

The American Urological Association (AUA) Annual Meeting serves as the premier platform for presenting unpublished research in urology. Among selected abstracts, podium presentations represent the most impactful submissions. While podium presentations receive a large audience through conference attendance and social media posts, it is unclear how often they manifest as publications in peer-reviewed journals. Podium presentations from the 2017 AUA Annual Meeting were reviewed. Abstracts were assessed for publication between January 1, 2015 and May 31, 2020 allowing for a 3-year window of publication and accounting for publications prior to the submission deadline. Abstract authors were individually searched with key terms being added sequentially until <30 results were generated in PubMed®. Abstracts were deemed published if at least 1 author and 1 conclusion matched a manuscript. Publication rate, time to publication, and 2019 journal impact factor were collected. Statistical analysis was performed by linear and logistic regression. Of 872 podium presentations, 453 (51.9%) were published within 3 years. Median time from submission to publication was 12.5 months (IQR: 7.5-20.5). The number of articles published at 1, 2 and 3 years from submission was 203, 368 and 430, respectively. The median journal impact factor of publications was 3.2 (IQR: 2.0-5.8). Oncology studies (OR=1.21 [95% CI: 0.91-1.60], p=0.186) had similar rates of publication compared to non-oncology studies. While AUA podium presentations disseminate valuable data, approximately half were not published in peer-reviewed journals within 3 years. Therefore, care must be taken when promoting findings or adopting new practices based on these presentations alone.

EDITORIAL COMMENT

Plenary speakership at national meetings serve as important career milestones within academic medicine, as they increase visibility and reputation of the presenter which ties heavily into career advancement and promotion.1 In this study, the authors describe contemporary patterns in female representation on plenary sessions at the American Urological Association Annual Meeting. Overall, 12% of panelists were women, and approximately 60% of panels during the study period were comprised solely of men.

Quantifying publication rates and time to publication for urologic oncology podium presentations.

357 Background: The American Urological Association (AUA) annual meetings serve as a large platform for unpublished research. Among the selected abstracts, podium presentations represent the most impactful submissions. Furthermore, between large meeting attendance and social media promotion, authors can disseminate their findings to a potentially large audience prior to final manuscript publication. While all AUA abstracts do undergo peer review, it is not with the same level of scrutiny that full-length manuscripts receive. Thus, we investigated the publication rates, impact factors, and time to publication of urologic oncology podium presentations at the AUA. Methods: Of 875 podium presentation abstracts from the 2017 AUA Annual meeting, 394 (45.0%) were classified as urologic oncology. We chose 2017 to allow for a three-year window for publication. Abstracts were assessed for subsequent publication between January 1, 2015 and May 31, 2020 with a pre-determined PubMed search protocol. Abstract authors were searched for individually, with key terms being added sequentially until &lt;30 results were generated in PubMed. Each search result was then reviewed until a matching publication was found. Abstracts were deemed published if at least one author of the presented abstract was a manuscript author and/or at least one conclusion in the presented abstract was included in the conclusions of the publication. Publication rates, time to publication, and 2019 journal impact factors were collected. Results: Of 394 urologic oncology podium presentations at the 2017 AUA, 228 (57.9%) focused on prostate cancer, while 81 (20.6%) and 58 (14.7%) presentations focused on kidney and bladder cancer, respectively (table). Overall, 211 (53.6%) podium presentations were published. Median time from presentation to publication was 13.6 months (IQR: 7.5-21.5). There were 9 (2.3%) publications that were published prior to the submission deadline and 57 (14.5%) podium presentations that were published prior to the 2017 AUA meeting. The number of articles published at one, two and three years after the meeting was 90, 170 and 202, respectively. The median journal impact factor of all published works was 3.4 (IQR: 2.7-5.9). Conclusions: While AUA podium presentations disseminate valuable data, approximately half of these presentations were not published in peer-reviewed journals within three years. Therefore, care must be taken when promoting data or adopting new practices based on these presentations alone. [Table: see text]

Gender Representation Among Plenary Panel Speakers at the American Urological Association Annual Meeting

ObjectiveTo examine trends in the representation of women in plenary panels at the American Urological Association (AUA) Annual Meeting. MethodsA review of all plenary sessions from AUA Annual Meetings during 2017-2019 was performed. The number and proportion of invited moderators and panelists by gender were recorded and analyzed by the topic of each plenary session. We performed descriptive analyses and tested temporal trends in gender representation. ResultsA total of 168 plenary panels were held at the AUA meetings, 62 panels in 2017, 51 panels in 2018, and 55 panels in 2019. Overall, 59% of panels were all-male panels (61% in 2017, 67% in 2018, and 49% in 2019) with exclusively male moderators and panelists. There was no significant change in the proportion of all-male panels during the study period (P = .20). Among the 168 panels, 153 (91%) had a male moderator, and 107 (64%) had only male panelists. Seventy-five unique female speakers accounted for 90 (12%) of the 742 total panel speaking roles. There was significant variation in the proportion of female speakers among 6 plenary topics (P = .03); the overall proportion of all-male panels was highest for sexual medicine sessions (14 of 18 panels, 78%) and lowest for female pelvic medicine sessions (5 of 19 panels, 26%). ConclusionFemale representation in plenary panels at recent AUA Annual Meetings did not significantly change, with the majority of panels composed entirely of male speakers. Continued evaluation of these trends may inform efforts to achieve gender equality at national urology meetings.

The Durability of Active Surveillance in Patients with Asymptomatic Kidney Stones: A Systematic Review.

Introduction: The natural progression of asymptomatic kidney stones remains unclear. Such knowledge may promote value-aligned care for patients and reduce potentially unnecessary procedures. We sought to evaluate the natural history of asymptomatic kidney stones in adults undergoing active surveillance. Materials and Methods: Using themes of "Kidney Stone" and "Active Surveillance," we performed a systematic review by searching for studies in MEDLINE, all Cochrane libraries, EMBASE, Cumulative Index to Nursing and Allied Health Literature, BIOSIS, Scopus, and Web of Science from inception through October 2017-in addition to ClinicalTrials.gov, American Urological Association Annual Meeting abstracts (2014-2017), Google Scholar, and references of included studies and prior reviews. Two blinded reviewers independently extracted data and assessed methodological quality. We qualitatively summarized rates of surgical intervention (primary outcome), spontaneous stone passage, symptom development, and stone growth. We assessed the relationship between surveillance duration and rate of surgical intervention with Pearson's correlation coefficient. Results: Of 7034 unique records, 13 studies met final eligibility criteria. There was substantial variation in reported rates of surgical intervention from 6/85 (7.1%) to 80/301 (26.6%), spontaneous stone passage from 1/32 (3.1%) to 101/347 (29.1%), symptom development from 7/96 (7.3%) to 231/300 (77.0%), and stone growth from 5/96 (5.2%) to 33/50 (66.0%). Mean surveillance duration spanned from 11.3 to 80 months (range 2-180 months). Longer mean duration of surveillance did not correlate with an increase in surgical intervention rate across studies (n = 13, r = 0.01, p = 0.98), and this finding persisted when restricting analysis to observational studies (n = 9, r = 0.12, p = 0.76). Conclusions: Active surveillance appears to be a durable strategy for a majority of patients with asymptomatic kidney stones, as there was no increase in failure of watchful waiting despite increasing duration of surveillance. Higher quality studies are needed to ascertain which patients may benefit most from active surveillance.

Best of the 2017 AUA Annual Meeting: Highlights From the 2017 American Urological Association Annual Meeting, May 12-16, 2017, Boston, MA.

Best of the 2017 AUA Annual Meeting: Highlights From the 2017 American Urological Association Annual Meeting, May 12-16, 2017, Boston, MA.

Prof. Mitchell Humphreys: a pioneer in the natural orifice translumenal endoscopic surgery (NOTES)

The 2016 American Urological Association (AUA) Annual Meeting was held grandly in the San Diego Convention Center, USA from May 6th to May 10th. During the annual meeting, many new researches were shared and discussed. This time, the Editorial Office of Translational Andrology and Urology ( TAU ) was honored to invite Prof. Mitchell Humphreys ( Figure 1 ), from Mayo Clinic Arizona, to have an interview with us.

Prof. Rajeev Kumar: adrenal masses

The 111th American Urological Association Annual Meeting 2016 (AUA 2016) was held successfully in San Diego Convention Center, San Diego, USA from May 6th to May 10th, 2016. It is the largest scientific meeting to gather together urologists in the world and to provide latest advances in urologic medicine.

Prof. Allen Seftel: be part of new innovations

The 2016 American Urological Association Annual Meeting was held grandly in the San Diego Convention Center, USA from May 6 th to 10 th . During the annual meeting, many news researches were shared and discussed. This time, the Editorial Office of Translational Andrology and Urology ( TAU ) was honored to invite Prof. Allen Seftel ( Figure 1 ), from Cooper University Hospital, to have an interview with us.

Dr. Ryan P. Smith: management of chronic orchialgia

The 111 th American Urological Association Annual Meeting 2016 (AUA 2016) was held successfully in San Diego Convention Center, San Diego, USA from May 6 th to 10 th , 2016. It is the largest scientific meeting to gather together urologists in the world and to provide latest advances in urologic medicine.

Dr. Jeffrey Tomaszewski: the application of prostate cancer genomic tests

The 2016 American Urological Association (AUA) Annual Meeting was held grandly in the San Diego Convention Center, USA from May 6th to May 10th. During the annual meeting, many new researches were shared and discussed. This time, the Editorial Office of Translational Andrology and Urology ( TAU ) was honored to invite Dr. Jeffrey Tomaszewski ( Figure 1 ), from Cooper Medical School of Rowan University, to have an interview with us.

Best of the 2016 AUA Annual Meeting: Highlights From the 2016 American Urological Association Annual Meeting, May 6-10, 2016, San Diego, CA.

Best of the 2016 AUA Annual Meeting: Highlights From the 2016 American Urological Association Annual Meeting, May 6-10, 2016, San Diego, CA.

Novel survey disseminated through Twitter supports its utility for networking, disseminating research, advocacy, clinical practice and other professional goals.

Twitter use has grown exponentially within the urological community. We aimed to determine the perceptions of the impact of Twitter on users' clinical practice, research, and other professional activities. We performed an 11-item online survey of Twitter contributors during two major urological meetings: the European Association of Urology (EAU) and the American Urological Association (AUA) annual meetings. During the EAU 2014 meeting, we distributed the survey via the meeting official Twitter feed. During the AUA 2014 meeting, we applied a new method by directly sending the survey to Twitter contributors. We performed a subset analysis for assessing the perceived impact of Twitter on the clinical practice of physicians. Among 312 total respondents, the greatest perceived benefits of Twitter among users were for networking (97%) and disseminating information (96%), followed by research (75%), advocacy (74%) and career development (62%). In total, 65% of Twitter users have dealt with guidelines on online medical professionalism and 71% of physician users found that Twitter had an impact on their clinical practice, and 33% had made a clinical decision based on an online case discussion. Our results suggest that Twitter users in the urological community perceive important benefits. These benefits extend to multiple professional domains, particularly networking, disseminating information, remote conference participation, research, and advocacy. This is the first study that has been disseminated to targeted individuals from the urological community directly through tweets, providing a proof of principle for this research method.

MP55-04 THERMOTHERAPY WITH MAGNETIC CATIONIC LIPOSOMES POWERFULLY SUPPRESSES PROSTATE CANCER BONE METASTASIS IN A NOVEL RAT MODEL

You have accessJournal of UrologyProstate Cancer: Basic Research III1 Apr 2015MP55-04 THERMOTHERAPY WITH MAGNETIC CATIONIC LIPOSOMES POWERFULLY SUPPRESSES PROSTATE CANCER BONE METASTASIS IN A NOVEL RAT MODEL Daichi Kobayashi, Noriyasu Kawai, Keitaro Iida, Toshiki Etani, Taku Naiki, Ryosuke Ando, Keiichi Tozawa, Tohru Mogami, and Kenjiro Kohri Daichi KobayashiDaichi Kobayashi More articles by this author , Noriyasu KawaiNoriyasu Kawai More articles by this author , Keitaro IidaKeitaro Iida More articles by this author , Toshiki EtaniToshiki Etani More articles by this author , Taku NaikiTaku Naiki More articles by this author , Ryosuke AndoRyosuke Ando More articles by this author , Keiichi TozawaKeiichi Tozawa More articles by this author , Tohru MogamiTohru Mogami More articles by this author , and Kenjiro KohriKenjiro Kohri More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.2047AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Bone metastasis is a serious problem for prostate cancer patients, and the anticancer drug docetaxel (DTX) does not effectively treat this condition. Therefore, new therapies are urgently required. At the American Urological Association annual meetings in 2007, 2008, and 2010, we reported the therapeutic effects of our magnetite nanoparticles conjugated with cationic liposomes (MCLs). Here, we examined the therapeutic potential of MCLs for bone metastasis from prostate cancer compared to conventional DTX therapy in a novel rat model that allows tumor immunity evaluation. METHODS Prostate tumor tissues were transplanted into the femurs of 4 groups of model rats: control, MCL, DTX, and MCL + DTX. Tumors were injected with MCLs, and alternating magnetic field (AMF) irradiation was performed thrice a week. We poured 200 μl MCLs (33 mg/ml) into the tumor center just before each AMF exposure from 4 directions. DTX (10 mg/kg) was administered transcaudally. Tumor proliferation and bone destruction were evaluated by examining proliferating cell nuclear antigen positivity, computed tomography images, and CD68-positive cell numbers. Tumor immunity was evaluated by assessing interleukin-2 (IL-2), interferon-gamma (IFN-γ), and heat shock protein (HSP) 70 expression and determination of the CD8-positive lymphocyte number. RESULTS We successfully established a novel femur metastasis model of prostate cancer. This model allows long-term evaluation of bones and immune function. Tumor proliferation and bone destruction were significantly lower in the MCL and MCL + DTX groups than in the control and DTX groups. MCL thermotherapy concurrently induced necrosis and apoptosis. IL-2, IFN-γ, and HSP70 expression in the MCL and MCL + DTX groups also significantly increased, and tumor immunity was enhanced through CD8-positive lymphocyte induction. CONCLUSIONS MCL thermotherapy selectively heats MCL-injected tumor tissues, inducing necrotic and apoptotic cancer cell death, tumor immunity, and suppression of bone destruction. MCL thermotherapy was clearly more effective than DTX in treating bone metastatic prostate cancer. Therefore, combined MCL thermotherapy and DTX deserves consideration as a novel treatment for this disease. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e674 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Daichi Kobayashi More articles by this author Noriyasu Kawai More articles by this author Keitaro Iida More articles by this author Toshiki Etani More articles by this author Taku Naiki More articles by this author Ryosuke Ando More articles by this author Keiichi Tozawa More articles by this author Tohru Mogami More articles by this author Kenjiro Kohri More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Brazilian abstracts presented at the American Urological Association annual meetings: contribution, publication rates, and comparison with oncology abstracts.

Scientific research originating from Brazil appears to be rising in several medical fields. Research results are often presented at scientific meetings before publication in peer-reviewed journals. We investigated the publication rate of Brazilian studies presented in American Urological Association (AUA) meetings and compared with the rate of publication of Brazilian oncological studies presented at the American Society of Clinical Oncology (ASCO) meetings. a hand search of 12,454 abstracts presented at aua meetings 2001-2007 was conducted. abstracts for which at least two-thirds of institutions were from brazil were considered as brazilian. final publication was searched in pubmed and lilacs databases. oncological abstracts were also hand searched in the asco meetings proceedings in the same years. There was no significant temporal trend in the proportion of AUA studies originating from Brazil along those 7 years. A total of 195 abstracts (1.57%) were from Brazil. One hundred (51.3%) abstracts were published in full, and the estimated 5-year publication rate was 48.2%. There was a progressive increase in publication rates for studies categorized as video, poster, and podium presentations. Considering abstracts presented in years 2001-2005, urologic publication rate was significantly higher than for abstracts presented at the ASCO meeting. Our results suggest that the Brazilian contribution to AUA meetings is at a plateau and that the Brazilian literature contribution is greater in urology than in oncology. Efforts must be invested towards raising this plateau and understanding qualitative aspects of the urology scientific output from Brazil.

Use of social media in urology: data from the American Urological Association (AUA)

To characterise the use of social media among members of the American Urological Association (AUA), as the use of social media in medicine has greatly expanded in recent years. In December 2012 to January 2013, the AUA e-mailed a survey with 34 questions on social media use to 2000 randomly selected urologists and 2047 resident/fellow members. Additional data was collected from Symplur analytics on social media use surrounding the AUA Annual Meeting in May 2013. In all, 382 (9.4%) surveys were completed, indicating 74% of responders had an online social media account. The most commonly used social media platforms were Facebook (93%), followed in descending order by LinkedIn (46%), Twitter (36%) and Google+ (26%). Being aged <40 years was an important predictor of social media use (83% vs 56%), with greater uptake among residents/fellows compared with attendings (86% vs 66%). Only 28% of respondents used social media partly or entirely for professional purposes. During the 2013 AUA Annual Meeting, there were >5000 tweets from >600 distinct contributors. As of early 2013, among respondents to an e-mail survey, most urologists and urology trainees used some form of social media, and its use in urology conferences has greatly expanded.